About Chiltern
Chiltern is a company based in Sacramento (United States) founded in 1986 was acquired by Chiltern International in July 2014.. Chiltern has completed 1 acquisition, including Nexus Oncology. Chiltern operates in a competitive market with competitors including Helsinn, Aster Insights, CancerVax, Abogen Biosciences and OnCusp, among others.
- Headquarter Sacramento, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$4.5 M (USD), Debt – Conventional
Jan 31, 2012
-
Investors
Chiltern International
& 1 more
-
Employee Count
Employee Count
- Investments & Acquisitions
-
Acquired by
Chiltern International
(Jul 15, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Chiltern
- Total Funding Total Funding
- Total Rounds 1
- Last Round Debt – Conventional — $4.5M
-
First Round
First Round
(31 Jan 2012)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2012 | Amount | Debt – Conventional - Chiltern | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Chiltern
Chiltern has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Chiltern International and Spring Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Flexible junior capital solutions are offered to growing businesses.
|
Founded Year | Domain | Location | |
|
Full service CRO with expertise in oncology related development services
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Chiltern
Chiltern has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Nexus Oncology. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Specialist oncology clinical research services for drug trials were provided.
|
1999 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Chiltern
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Chiltern Comparisons
Competitors of Chiltern
Chiltern operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helsinn, Aster Insights, CancerVax, Abogen Biosciences and OnCusp, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Oncology therapeutics are developed, manufactured, and commercialized by Helsinn.
|
|
| domain | founded_year | HQ Location |
Contract-based oncology clinical trial services are provided by Aster Insights.
|
|
| domain | founded_year | HQ Location |
Cancer vaccine research and development is conducted by CancerVax.
|
|
| domain | founded_year | HQ Location |
mRNA-based therapeutics are developed for cancer and infectious diseases.
|
|
| domain | founded_year | HQ Location |
CRO offering clinical development services for oncology drugs
|
|
| domain | founded_year | HQ Location |
Preclinical and clinical oncology drug development services are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Chiltern
When was Chiltern founded?
Chiltern was founded in 1986 and raised its 1st funding round 26 years after it was founded.
Where is Chiltern located?
Chiltern is headquartered in Sacramento, United States. It is registered at Sacramento, California, United States.
What does Chiltern do?
Ockham was a full-service oncology CRO with headquarters in North America and Europe and a presence in 12 countries in 4 continents. The company claims to have conducted 350 oncology-related Phase I-III clinical trials since its inception. Ockhams service portfolio included Scientific Affairs, Clinical Operations, Feasibility, Medical Affairs, Data Management and Biometrics. They catered to the needs of biopharmaceutical and medical device companies trying to develop oncology therapies. Ockham acquired Nexus Oncology, a 120 member strong UK-based oncology CRO, conducting Phase I-III oncology clinical trials across Europe, North America and Australasia in 2012. Post their acquisition by Chiltern, they offer their services through Chiltern Oncology, one of the 3 major divisions of Chiltern.
Who are the top competitors of Chiltern?
How many acquisitions has Chiltern made?
Chiltern has made 1 acquisition, including Nexus Oncology.
Who are Chiltern's investors?
Chiltern has 2 investors. Key investors include Chiltern International, and Spring Capital Partners.